Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs TrueMe

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, TrueMe a 74. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

TrueMe

#164 · Grade C+ · Watch List

Est. first month

From $159/mo (compounded)

Save ~88% vs brand-name
Get this deal Full TrueMe review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 74 an est. $99/mo first month, with no teaser step-up baked in. TrueMe isn't out of it: Shoppers who want flat all-inclusive GLP-1 pricing with no membership fee, if you live in one of its six states.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDTrueMe
Value Score89 (A)74 (C+)
Est. first month$99/moFrom $159/mo (compounded)
Save vs brand-name~93%~88%
Semaglutide$99/moFrom $159/mo (compounded)
Tirzepatide$139/moFrom $189/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states6 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
80
bmiMD: 95. TrueMe: 80.
84
No Teaser-Rate Bait
62
bmiMD: 84. TrueMe: 62.
98
Nationwide Availability
40
bmiMD: 98. TrueMe: 40.
94
Both Molecules
92
bmiMD: 94. TrueMe: 92.
82
Easy Cancellation
90
bmiMD: 82. TrueMe: 90.
70
Reputation
74
bmiMD: 70. TrueMe: 74.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

TrueMe

TrueMe is a cash-pay telehealth brand offering compounded semaglutide and tirzepatide with added B vitamins, alongside NAD+, sermorelin and glutathione.

Why it's a deal

  • One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
  • Same price at every dose, so the cost does not climb as a provider titrates the dose upward
  • Full pricing is published up front — no intake form is required before you can see what you will pay
  • Carries a genuine LegitScript-issued seal (ID 50205625) that resolves on LegitScript's own asset host
  • Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas

The fine print

  • Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
  • Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
  • You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
  • The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
  • A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage
Get the bmiMD deal Get the TrueMe deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to TrueMe.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.